Acadian Asset Management LLC bought a new position in Genpact Limited (NYSE:G - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 23,676 shares of the business services provider's stock, valued at approximately $1,191,000.
Other hedge funds also recently bought and sold shares of the company. Cornerstone Planning Group LLC purchased a new stake in Genpact during the first quarter valued at $27,000. Richardson Financial Services Inc. purchased a new stake in Genpact during the first quarter valued at $35,000. SVB Wealth LLC purchased a new stake in Genpact during the first quarter valued at $41,000. Kestra Investment Management LLC purchased a new stake in Genpact during the first quarter valued at $56,000. Finally, Global X Japan Co. Ltd. purchased a new stake in Genpact during the first quarter valued at $57,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the stock. Mizuho upped their price target on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. JPMorgan Chase & Co. cut their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Genpact in a report on Thursday, July 17th. They issued a "hold" rating and a $47.00 target price for the company. Wall Street Zen downgraded shares of Genpact from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Finally, Needham & Company LLC upped their price target on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a report on Friday, August 8th. Three investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $52.29.
View Our Latest Research Report on G
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 55,000 shares of Genpact stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the transaction, the chief executive officer owned 295,246 shares in the company, valued at $12,801,866.56. The trade was a 15.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Piyush Mehta sold 76,902 shares of Genpact stock in a transaction on Friday, September 12th. The stock was sold at an average price of $42.58, for a total value of $3,274,487.16. Following the transaction, the senior vice president owned 134,880 shares in the company, valued at approximately $5,743,190.40. This represents a 36.31% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.
Genpact Stock Performance
Shares of NYSE G traded down $0.17 during midday trading on Friday, reaching $41.13. 5,115,371 shares of the stock were exchanged, compared to its average volume of 1,768,660. The firm has a market cap of $7.17 billion, a price-to-earnings ratio of 13.66, a PEG ratio of 1.41 and a beta of 0.92. Genpact Limited has a twelve month low of $37.82 and a twelve month high of $56.76. The firm has a 50-day simple moving average of $44.05 and a two-hundred day simple moving average of $45.45. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The firm had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same quarter last year, the company earned $0.79 EPS. The firm's revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's payout ratio is 22.59%.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.